28
Views
3
CrossRef citations to date
0
Altmetric
Original Papers

The Prognostic Value of Post-operative Serum C-reactive Protein Level for Survival after Surgery for Colorectal Liver Metastases

, , &

References

  • Coussens L. M., Werb Z. Inflammation and cancer. Nature, 2002, 420: 860–867.
  • Elinav E., Nowarski R., Thaiss C. A., Hu B., Jin C., Flavell R. A. Inflammation-induced cancer: crosstalk between tumors, immune cells and microorganisms. Nat Rev Cancer, 2013, 13: 759–771.
  • Grivennikov s. I., Greten F. R., Karin M. Immunity, inflammation, and cancer. Cell, 2010, 140: 883–899.
  • Jagdev s. P., Gregory W., vasudev N. s. et al. Improving the accuracy of pre-operative survival prediction in renal cell carcinoma with C-reactive protein. Br J Cancer, 2010, 103: 16491656.
  • Roxburgh C. s., McMillan D. C. Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. Future Oncol, 2010, 6: 149–163.
  • Nozoe T., saeki H., sugimachi K. Significance of preoperative elevation of serum C-reactive protein as an indicator of prognosis in esophageal carcinoma. Am J Surg, 2001, 182: 197–201.
  • Nozoe T., Matsumata T., Kitamura M., sugimachi K. Significance of preoperative elevation of serum C-reactive protein as an indicator for prognosis in colorectal cancer. Am J Surg, 1998, 176: 335–338.
  • McMillan D. C., Canna K., McArdle C. S. Systemic inflammatory response predicts survival following curative resection of colorectal cancer. Br J Surg, 2003, 90: 215–219.
  • McMillan D. C., Wotherspoon H. A., Fearon K. C., sturgeon C., Cooke T. G., McArdle C. s. A prospective study of tumor recurrence and the acute-phase response after apparently curative colorectal cancer surgery. Am J Surg, 1995, 170: 319–322.
  • Koike Y., Miki C., okugawa Y. et al. Preoperative C-reactive protein as a prognostic and therapeutic marker for colorectal cancer. J Surg Oncol, 2008, 98: 540–544.
  • Erlinger T. P., Platz E. A., Rifai N., Helzlsouer K. J. C-reactive protein and the risk of incident colorectal cancer. JAMA, 2004, 291: 585–590.
  • Il’yasova D., Colbert L. H., Harris T. B. et al. Circulating levels of inflammatory markers and cancer risk in the health aging and body composition cohort. Cancer Epidemiol Biomarkers Prev, 2005, 14: 2413–2418.
  • Tsilidis K. K., Branchini C., Guallar E., Helzlsouer K. J., Erlinger T. P., Platz E. A. C-reactive protein and colorectal cancer risk: a systematic review of prospective studies. Int J Cancer, 2008, 123: 1133–1140.
  • Philip M., Rowley D. A., schreiber H. Inflammation as a tumor promoter in cancer induction. Semin Cancer Biol, 2004, 14: 433439.
  • Heikkila K., Ebrahim s., Lawlor D. A. A systematic review of the association between circulating concentrations of C reactive protein and cancer. J Epidemiol Community Health, 2007, 61: 824–833.
  • stolz D. B., Mars W. M., Petersen B. E., Kim T. H., Michalopoulos G. K. Growth factor signal transduction immediately after two-thirds partial hepatectomy in the rat. Cancer Res, 1999, 59: 3954–3960.
  • Radinsky R. Modulation of tumor cell gene expression and phenotype by the organ-specific metastatic environment. Cancer Metastasis Rev, 1995, 14: 323–338.
  • de Jong K. P., slooff M. J., de Vries E. G., Brouwers M. A., Terpstra o. T. Effect of partial liver resection on tumor growth. J Hepatol, 1996, 25: 109–121.
  • Fong Y., Fortner J., sun R. L., Brennan M. F., Blumgart L. H. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg, 1999, 230: 309–318; discussion 18–21.
  • Tillett W. S., Francis T. Serological Reactions in Pneumonia with a Non-Protein Somatic Fraction of Pneumococcus. J Exp Med, 1930, 52: 561–571.
  • McMillan D. C., Crozier J. E., Canna K., Angerson W. J., McArdle C. S. Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer. Int J Colorectal Dis, 2007, 22: 881–886.
  • Kobayashi T., Teruya M., Kishiki T. et al. Elevated C-reactive protein and hypoalbuminemia measured before resection of colorectal liver metastases predict postoperative survival. Dig Surg, 2010, 27: 285–290.
  • Nakagawa K., Tanaka K., Nojiri K. et al. The modified Glasgow prognostic score as a predictor of survival after hepatectomy for colorectal liver metastases. Ann Surg Oncol, 2014, 21: 17111718.
  • Ishizuka M., Kita J., Shimoda M. et al. Systemic inflammatory response predicts postoperative outcome in patients with liver metastases from colorectal cancer. J Surg Oncol, 2009, 100: 3842.
  • Hamilton T. D., Leugner D., Kopciuk K., Dixon E., Sutherland F. R., Bathe O. F. Identification of prognostic inflammatory factors in colorectal liver metastases. BMC Cancer, 2014, 14: 542.
  • de Jong K. P., Hoedemakers R. M., Fidler V. et al. Portal and systemic serum growth factor and acute-phase response after laparotomy or partial hepatectomy in patients with colorectal liver metastases: a prognostic role for C-reactive protein and hepatocyte growth factor. Scand J Gastroenterol, 2004, 39: 1141–1148.
  • Morris-Stiff G., Gomez D., Prasad K. R. C-reactive protein in liver cancer surgery. Eur J Surg Oncol, 2008, 34: 727–729.
  • Wong v. K., Malik H. Z., Hamady Z. Z. et al. C-reactive protein as a predictor of prognosis following curative resection for colorectal liver metastases. Br J Cancer, 2007, 96: 222–225.
  • Picardo A., Karpoff H. M., Ng B., Lee J., Brennan M. F., Fong Y. Partial hepatectomy accelerates local tumor growth: potential roles of local cytokine activation. Surgery, 1998 Jul, 124: 57–64.
  • Asaga T., Suzuki K., umeda M., Sugimasa Y., Takemiya S., okamoto T. The enhancement of tumor growth after partial hepatectomy and the effect of sera obtained from hepatectomized rats on tumor cell growth. Jpn J Surg, 1991, 21: 669–675.
  • de Jong K. P., Lont H. E., Bijma A. M. et al. The effect of partial hepatectomy on tumor growth in rats: in vivo and in vitro studies. Hepatology, 1995, 22: 1263–1272.
  • Mizutani J., Hiraoka T., Yamashita R., Miyauchi Y. Promotion of hepatic metastases by liver resection in the rat. Br J Cancer, 1992, 65: 794–797.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.